Regulator Says Pfizer Used Misleading Advertisement

Law360, New York (August 14, 2007, 12:00 AM EDT) -- Federal Regulators took drug company Pfizer Inc. to task on Monday for using misleading claims about the schizophrenia drug Geodon in an advertisement the drug company published in a professional journal.

The U.S. Food and Drug Administration posted a letter it had written to Pfizer on its Web site Monday, in which it claimed Pfizer's advertisement misbranded the drug in violation of the Federal Food, Drug and Cosmetic Act.

Geodon is used to treat acute agitation in schizophrenic patients. The FDA said the drug is associated...
To view the full article, register now.